Balance Sheet: Assets
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.
Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Analysis of Geographic Areas
- Common Stock Valuation Ratios
- Enterprise Value to FCFF (EV/FCFF)
- Return on Equity (ROE) since 2005
- Return on Assets (ROA) since 2005
- Price to Earnings (P/E) since 2005
- Price to Operating Profit (P/OP) since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Abbott Laboratories, consolidated balance sheet: assets
US$ in millions
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
- Cash and Cash Equivalents
- The cash and cash equivalents exhibit volatility over the reported periods. After increasing significantly from 6,838 million USD at the end of 2020 to 9,799 million USD by the end of 2021, the value plateaued in 2022 at 9,882 million USD before declining notably to 6,896 million USD in 2023. A partial recovery to 7,616 million USD is observed in 2024, suggesting fluctuations in liquidity management or cash utilization.
- Investments (Primarily Bank Time Deposits and U.S. Treasury Bills)
- Investments fluctuated within a moderate range, peaking at 450 million USD in 2021 and decreasing to a low of 288 million USD in 2022. The value then rose to 383 million USD in 2023, followed by a slight decrease to 351 million USD in 2024. This pattern indicates a relatively stable but cautiously managed investment portfolio with minor reallocations.
- Trade Receivables, Less Allowances
- Trade receivables remained generally stable with a slight upward trend, moving from 6,414 million USD in 2020 to 6,925 million USD in 2024. The gradual increase suggests consistent or improving sales on credit and effective collections management.
- Inventories
- Inventory values demonstrate growth from 5,012 million USD in 2020 to a peak of 6,570 million USD in 2023, followed by a reduction to 6,194 million USD in 2024. This indicates expansion in stock holdings up to 2023 with possible inventory optimization or sales acceleration in 2024.
- Other Prepaid Expenses and Receivables
- These assets increased from 1,867 million USD in 2020 to a high of 2,663 million USD in 2022, then declined to 2,256 million USD in 2023, and rose again to 2,570 million USD in 2024. The fluctuations might reflect changes in operating expenses or timing differences in payments and accruals.
- Current Assets
- Current assets exhibited general growth, climbing from 20,441 million USD in 2020 to a peak of 25,224 million USD in 2022, followed by a decrease to 22,670 million USD in 2023 and a partial recovery to 23,656 million USD in 2024. This pattern aligns with the components of cash, receivables, and inventories, illustrating overall liquidity dynamics.
- Equity Securities
- Values declined steadily from 776 million USD in 2020 to 553 million USD in 2024, indicating a reduction in holdings of equity investments or a decline in market valuations.
- Other Current Assets
- This category expanded significantly, rising from 45 million USD in 2020 to 333 million USD by 2024, which might point to new or increased miscellaneous short-term assets.
- Long-term Investments
- Long-term investments remained relatively steady with minor fluctuations, ranging between 766 and 886 million USD from 2020 to 2024. This suggests a stable strategy in holding non-current investments.
- Net Property and Equipment
- The net value of property and equipment exhibits an ascending trend, growing from 9,029 million USD in 2020 to 10,658 million USD in 2024. This increase suggests ongoing capital expenditures or asset enhancements over the period.
- Intangible Assets, Net of Amortization
- Intangible assets declined consistently from 14,784 million USD in 2020 to 6,647 million USD in 2024. This marked decrease reflects amortization or possible impairment charges reducing the net book value of intangible assets substantially over time.
- Goodwill
- Goodwill decreased gradually from 23,744 million USD in 2020 to 23,108 million USD in 2024, with relatively small fluctuations. The slight reduction could be attributed to impairment or foreign exchange impacts.
- Deferred Income Taxes and Other Assets
- These assets rose significantly, from 3,729 million USD in 2020 to 16,459 million USD in 2024. This sharp increase suggests accumulation of deferred tax assets or other long-term non-current assets, impacting the total asset base notably.
- Long-term Assets
- Long-term assets show a moderate decline from 52,107 million USD in 2020 to 49,214 million USD in 2022, followed by a rebound to 57,758 million USD by 2024. The increase is consistent with the growth observed in deferred income taxes and net property and equipment.
- Total Assets
- Total assets rose from 72,548 million USD in 2020 to a peak of 75,196 million USD in 2021, then declined to 73,214 million USD in 2023 before increasing sharply to 81,414 million USD in 2024. The recent growth mostly reflects increases in long-term assets, particularly deferred income taxes and property assets, suggesting strategic investments or adjustments to asset base.